White Paper

Strategies for Accelerating the Development of Modified Release Oral Forms

Our facilities

Quotient Sciences operates from state-of-the-art manufacturing and clinical facilities in the U.S. and U.K.

Our facilities include two clinical pharmacology units, two purpose-built pharmaceutical development and manufacturing sites. We support you by working under FDA or MHRA guidelines and offer a full range of support services, from study setup through to data analysis and reporting.

Global formulation and manufacturing

  • Pharmaceutical development and manufacturing facilities in the U.S. and U.K.
  • Production of Phase I – Phase III clinical drug supplies
  • Commercial product manufacture for solid dosage forms and liquid formats
  • U.S. facility is FDA / EMA / PMDA approved, U.K. facility is MHRA approved
  • GMP manufacturing suites globally including high potent compound handling
  • Scalable manufacturing equipment for non-sterile dosage forms
  • Batch sizes ranging from small scale (200g) to large scale (500kg) for tablet and capsule drug products and up to 350L for liquid presentations
  • Clinical packaging, labeling and global distribution for Phase I – Phase IIb programs

Global clinical pharmacology

  • Two purpose built Phase I units in the U.S. (Miami) and U.K. (Nottingham)
  • >245 bed capacity across Miami (U.S.), and Nottingham (U.K.)
  • Experienced team of 16 physicians and principal investigators
  • >1,300 Phase I studies completed to date
  • Database of >25,000 active participants across a broad demographic
  • Medical writing, data management, pharmacokinetics, statistical analysis and reporting


Get in touch with us

Ready to get started?

Share Your Project Needs With Us

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.